Imperial College London

ProfessorElioRiboli

Faculty of MedicineSchool of Public Health

Director, School of Public Health
 
 
 
//

Contact

 

+44 (0)20 7594 1913e.riboli Website

 
 
//

Assistant

 

Ms Julieta Dourado +44 (0)20 7594 3426

 
//

Location

 

152Medical SchoolSt Mary's Campus

//

Summary

 

Summary

Professor Elio  Riboli is Director of the School of Public Health at Imperial College London, rated one of the top two epidemiology and public health submissions to the UK’s Research Assessment Exercise (RAE) in 2009. He holds an M.D. degree (1977, State University of Milan), a Master of Public Health (1980, Milan) and a Master of Science in Epidemiology (1982, Harvard University). Professor Riboli is a Registered Physician (General Medical Council, UK, 2005) and an Honorary Fellow of the Royal College of Physicians (2008).

From 1983 to 2005 Professor Riboli was based at Lyon’s the International Agency for Research on Cancer (IARC), where he developed new research projects in the areas of nutrition, nutritional status and cancer. In 1989 he initiated the European Prospective Investigation into Cancer and Nutrition (EPIC), which sampled data from 500,000 subjects across 26 centres in ten countries. He was Head of the Nutrition and Hormones Group of IARC from 2004 to 2005.

Professor Riboli has co-authored over 310 peer-reviewed publications and over 100 book chapters and books and serves on editorial boards of major journals on nutrition, cancer and epidemiology. 

In 2005 he joined Imperial College London as Professor of Cancer Epidemiology; in 2006 he was appointed Divisional Head of Epidemiology, Public Health and Primary Care, and became Director  when the School of Public Health was established in January 2010. 

 

Publications

Journals

Merritt MA, Tzoulaki I, van den Brandt PA, et al., Nutrient-wide association study of 57 foods/nutrients and epithelial ovarian cancer in the EPIC study and the NLCS, American Journal of Clinical Nutrition, ISSN:1938-3207

Riboli E, Interaction between genes and macronutrient intake on the risk of developing type 2 diabetes: systematic review and findings from EPIC-InterAct, American Journal of Clinical Nutrition, ISSN:1938-3207

Riboli E, Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study, Bmc Medicine, ISSN:1741-7015

Riboli E, Cross A, Coffee Drinking and Mortality in Ten European Countries – the EPIC Study, Annals of Internal Medicine, ISSN:1539-3704

Riboli E, cross A, Tsilidis K, Pre-diagnostic metabolite concentrations and prostate cancer risk in 1077 cases and 1077 matched controls in the European Prospective Investigation into Cancer and Nutrition, Bmc Medicine, ISSN:1741-7015

More Publications